These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2825270)

  • 1. [Diagnosis and therapy of ergotism following the use of heparin-DHE in thrombosis prevention].
    Wiesmann W; Peters PE; Irskens U; Schwering H
    Rofo; 1987 Oct; 147(4):446-9. PubMed ID: 2825270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ergotism of the lower extremities resulting from thrombosis prevention using DHE-heparin. An angiographic follow-up study].
    Warmuth-Metz M
    Radiologe; 1988 Oct; 28(10):491-3. PubMed ID: 3186973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergotism as complication of thromboembolic prophylaxis with heparin-dihydroergotamine.
    Rem JA; Gratzl O; Follath F; Pult I
    Lancet; 1987 Jan; 1(8526):219. PubMed ID: 2880045
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe vasospastic reactions (ergotism) during prophylactic administration of heparin-dihydroergotamine.
    Bounameaux H; Schneider PA; Mossaz A; Suter P; Vasey H
    Vasa; 1987; 16(4):370-2. PubMed ID: 3424957
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ergotism within the scope of the postoperative prevention of thromboembolism].
    Kneist W; Heesen U; Assmann H
    Zentralbl Chir; 1987; 112(22):1426-35. PubMed ID: 3439378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ergotism--a serious complication in the chemical prevention of thromboembolism with heparin-DHE].
    van den Berg E; Walterbusch G; Gotzen L; Rumpf KD; Otten B; Fröhlich H
    Vasa; 1983; 12(1):64-7. PubMed ID: 6837130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ergotism--a severe complication of drug prevention of thromboembolism].
    van den Berg E; Walterbusch G
    Dtsch Med Wochenschr; 1982 May; 107(18):716-8. PubMed ID: 7075489
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?].
    Rasche H; Vollmar J; Burri C; Beger HG; Kilian J; Kinzl J; Krautzberger W; Wenzke C
    Langenbecks Arch Chir; 1983; 360(2):81-95. PubMed ID: 6355715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complications following preventive treatment of thromboembolism with Dihydergot-heparin].
    Andersen KH; Jeppesen IS
    Ugeskr Laeger; 1989 Aug; 151(33):2072-5. PubMed ID: 2672498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ergotism--a risk in the prevention of thrombosis?].
    Jahn R
    Zentralbl Chir; 1985; 110(8):482-5. PubMed ID: 4002912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Ashenburg RJ
    J Bone Joint Surg Am; 1990 Jan; 72(1):153. PubMed ID: 2295668
    [No Abstract]   [Full Text] [Related]  

  • 12. Ergotism leading to threatened limb amputation or to death in two patients given heparin-dihydroergotamine prophylaxis.
    van den Berg E; Walterbusch G; Gotzen L; Rumpf KD; Otten B; Fröhlich H
    Lancet; 1982 Apr; 1(8278):955-6. PubMed ID: 6122783
    [No Abstract]   [Full Text] [Related]  

  • 13. Ergotism and heparin-dihydroergotamine [letter].
    Kakkar VV
    Lancet; 1982 Jul; 2(8289):96-7. PubMed ID: 6123829
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ergotism--an important complication of drug thromboembolism prevention].
    Krupp P; Meyer HE
    Dtsch Med Wochenschr; 1982 Jan; 107(1):36. PubMed ID: 7056149
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arterial vasospasm as a complication of the prevention of thromboembolism with heparin-dihydroergotamine and its treatment].
    Schott G; Riedel K
    Zentralbl Chir; 1986; 111(21):1354-7. PubMed ID: 3101315
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guides to ergotism, a too little recognized complication of trauma].
    Voigt J; Dortenmann J
    Aktuelle Traumatol; 1983 Feb; 13(1):46-9. PubMed ID: 6132532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular spasm and gangrene during heparin-dihydro-ergotamine prophylaxis.
    Cunningham M; de Torrenté A; Ekoé JM; Ackermann JP; Humair L
    Br J Surg; 1984 Nov; 71(11):829-31. PubMed ID: 6498453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5 years' general drug prevention of thromboembolism in general surgery. Comparison of personal experiences with results from the literature].
    Voigt J; Lennert K; Hedderich J
    Fortschr Med; 1984 May; 102(20):562-4. PubMed ID: 6735335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of thromboembolism in accident surgery--angiospastic complications with DHE-heparin. A multicenter study].
    Gatterer R; Wruhs O; Havelec L; Polterauer P; Marosi L
    Unfallchirurgie; 1987 Oct; 13(5):263-70. PubMed ID: 3321657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroergotamine-heparin to prevent postoperative deep vein thrombosis.
    Med Lett Drugs Ther; 1985 May; 27(688):45-6. PubMed ID: 3889570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.